查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1819875

COVID-19 诊断市场报告，按产品类型、样本类型、测试类型（分子测试、抗原测试、抗体测试等）、模式（即时诊断、非即时诊断）、最终用途和地区划分，2025 年至 2033 年

COVID-19 Diagnostics Market Report by Product Type, Sample Type, Test Type (Molecular Testing, Antigen-based Testing, Antibody Testing, and Others), Mode (Point-of-Care, Non-Point-of-Care ), End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球 COVID-19 诊断市场规模达 583 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 290 亿美元。

COVID-19 诊断是指为检测个体是否有病毒感染而进行的临床检测。 COVID-19 是由新发现的人畜共通冠状病毒引起的传染病。一些常见症状包括发烧、疲劳、干咳、呼吸急促、喉咙痛和身体疼痛。病毒感染通常透过逆转录聚合酶链反应 (RT-PCR)、抗原和抗体检测来诊断。这些检测使用试剂和试剂盒从鼻咽拭子 (NP)、口咽拭子 (OP) 和鼻腔拭子、人体唾液或血液中取得样本。它们广泛应用于医院、实验室、诊所、研究机构和诊断中心。

新冠病毒疫情的突然爆发以及全球新冠肺炎病例数量的惊人增长，是市场成长前景乐观的关键因素之一。每日新增病例数的持续成长促使诊断检测被广泛采用，以便快速、全面地进行检测，从而为患者提供早期治疗。同时，对大规模检测和分子诊断的需求日益增长，也促进了市场的成长。此外，各种产品创新，例如用于家庭检测的新型抗体和血清学检测试剂盒的推出，也成为其他成长的推动因素。与传统检测试剂盒相比，这些试剂盒耗时更少，并且可以与基于软体的程式整合以获得准确的结果。其他因素，包括政府为防止新冠肺炎感染进一步蔓延而实施的优惠政策，以及医疗保健基础设施的显着改善（尤其是在发展中经济体），预计将推动市场成长。

本报告回答的关键问题

  • 2024年全球COVID-19诊断市场规模？ COVID-19对全球COVID-19诊断市场有何影响？
  • 推动全球 COVID-19 诊断市场发展的关键因素有哪些？
  • 根据产品类型，全球 COVID-19 诊断市场是如何分布的？
  • 根据样本类型，全球 COVID-19 诊断市场如何分布？
  • 根据测试类型，全球 COVID-19 诊断市场如何分布？
  • 根据模式，全球 COVID-19 诊断市场的分布如何？
  • 根据最终用途，全球 COVID-19 诊断市场的分布如何？
  • 全球 COVID-19 诊断市场的主要地区有哪些？
  • 全球 COVID-19 诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球 COVID-19 诊断市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 试剂和试剂盒
  • 仪器
  • 其他的

第七章：市场区隔：依样本类型

  • 鼻咽拭子
  • 口咽拭子
  • 鼻拭子
  • 血
  • 其他的

第 8 章：市场区隔：按测试类型

  • 分子（RT-PCR）检测
  • 基于抗原的检测
  • 抗体（血清学）检测
  • 其他的

第九章：市场细分：依模式

  • 护理点（PoC）
  • 非护理点（Non-PoC）

第 10 章：市场区隔：最终用途别

  • 实验室
  • 医院
  • 诊断中心和诊所
  • 其他的

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场趋势及预测
    • 加拿大
      • 市场趋势及预测
  • 亚太
    • 中国
      • 市场趋势及预测
    • 日本
      • 市场趋势及预测
    • 印度
      • 市场趋势及预测
    • 韩国
      • 市场趋势及预测
    • 澳洲
      • 市场趋势及预测
    • 印尼
      • 市场趋势及预测
    • 其他的
      • 市场趋势及预测
  • 欧洲
    • 德国
      • 市场趋势及预测
    • 法国
      • 市场趋势及预测
    • 英国
      • 市场趋势及预测
    • 义大利
      • 市场趋势及预测
    • 西班牙
      • 市场趋势及预测
    • 俄罗斯
      • 市场趋势及预测
    • 其他的
      • 市场趋势及预测
  • 拉丁美洲
    • 巴西
      • 市场趋势及预测
    • 墨西哥
      • 市场趋势及预测
    • 其他的
      • 市场趋势及预测
  • 中东和非洲
    • 市场趋势及预测
    • 市场区隔：依国家

第 12 章：SWOT 分析

第 13 章：价值链分析

第 14 章：波特五力分析

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories
    • Danaher Corporation
    • F. Hoffman-La Roche Ltd. (Roche Holding AG)
    • Luminex Corporation
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Robert Bosch GmbH
    • Seegene Inc.
    • Siemens Aktiengesellschaft
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A3552

The global COVID-19 diagnostics market size reached USD 58.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 29.0 Billion by 2033.

COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Product Type:

  • Reagents and Kits
  • Instruments
  • Others

Breakup by Sample Type:

  • Nasopharyngeal Swabs
  • Oropharyngeal Swabs
  • Nasal Swabs
  • Blood
  • Others

Breakup by Test Type:

  • Molecular (RT-PCR) Testing
  • Antigen-based Testing
  • Antibody (Serology) Testing
  • Others

Breakup by Mode:

  • Point-of-Care (PoC)
  • Non-Point-of-Care (Non-PoC)

Breakup by End Use:

  • Laboratories
  • Hospitals
  • Diagnostic Centers and Clinics
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global COVID-19 diagnostics market in 2024?
  • 2.What has been the impact of COVID-19 on the global COVID-19 diagnostics market?
  • 3.What are the key factors driving the global COVID-19 diagnostics market?
  • 4.What is the breakup of the global COVID-19 diagnostics market based on the product type?
  • 5.What is the breakup of the global COVID-19 diagnostics market based on the sample type?
  • 6.What is the breakup of the global COVID-19 diagnostics market based on the test type?
  • 7.What is the breakup of the global COVID-19 diagnostics market based on the mode?
  • 8.What is the breakup of the global COVID-19 diagnostics market based on the end use?
  • 9.What are the key regions in the global COVID-19 diagnostics market?
  • 10.Who are the key players/companies in the global COVID-19 diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COVID-19 Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends and Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends and Forecast
  • 6.3 Others
    • 6.3.1 Market Trends and Forecast

7 Market Breakup by Sample Type

  • 7.1 Nasopharyngeal Swabs
    • 7.1.1 Market Trends and Forecast
  • 7.2 Oropharyngeal Swabs
    • 7.2.1 Market Trends and Forecast
  • 7.3 Nasal Swabs
    • 7.3.1 Market Trends and Forecast
  • 7.4 Blood
    • 7.4.1 Market Trends and Forecast
  • 7.5 Others
    • 7.5.1 Market Trends and Forecast

8 Market Breakup by Test Type

  • 8.1 Molecular (RT-PCR) Testing
    • 8.1.1 Market Trends and Forecast
  • 8.2 Antigen-based Testing
    • 8.2.1 Market Trends and Forecast
  • 8.3 Antibody (Serology) Testing
    • 8.3.1 Market Trends and Forecast
  • 8.4 Others
    • 8.4.1 Market Trends and Forecast

9 Market Breakup by Mode

  • 9.1 Point-of-Care (PoC)
    • 9.1.1 Market Trends and Forecast
  • 9.2 Non-Point-of-Care (Non-PoC)
    • 9.2.1 Market Trends and Forecast

10 Market Breakup by End Use

  • 10.1 Laboratories
    • 10.1.1 Market Trends and Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends and Forecast
  • 10.3 Diagnostic Centers and Clinics
    • 10.3.1 Market Trends and Forecast
  • 10.4 Others
    • 10.4.1 Market Trends and Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends and Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends and Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends and Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends and Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends and Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends and Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends and Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends and Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends and Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends and Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends and Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends and Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends and Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends and Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends and Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends and Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends and Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends and Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends and Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends and Forecast
    • 11.5.2 Market Breakup by Country

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 bioMerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Danaher Corporation
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 F. Hoffman-La Roche Ltd. (Roche Holding AG)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Luminex Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Quest Diagnostics Incorporated
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Robert Bosch GmbH
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Seegene Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Siemens Aktiengesellschaft
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion USD), 2025-2033
  • Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2024
  • Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2024
  • Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2024
  • Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2024
  • Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: COVID-19 Diagnostics (Antibody-Testing- Serology) Market: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: COVID-19 Diagnostics (Point-of-Care - PoC) Market: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care - Non-PoC) Market: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million USD), 2025-2033
  • Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
  • Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
  • Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million USD), 2025-2033
  • Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million USD), 2025-2033
  • Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
  • Table 9: Global: COVID-19 Diagnostics Market: Key Players